Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 169

Sort by

Sort Order Select

Journal Articles

RIG-I Activation Is Critical for Responsiveness to Checkpoint Blockade

Simon Heidegger, MD, Alexander Wintges, Florian Stritzke, Katja Steiger, Paul-Albert Koenig, Thomas Engleitner, Julius Clemens Fischer, Vladimir Makarov, Christof Winter, Roland Rad, Marcel R.M. van den Brink, MD PhD, Jürgen Ruland, Florian Bassermann, MD PhD, Timothy Chan, Tobias Haas, MD, Hendrik Poeck, MD

Blood (2019) 134 (Supplement_1): 624.

https://doi.org/10.1182/blood-2019-128724

Published: 2019

Journal Articles

Skin Associated Staphylococcus Aureus Contributes to Disease Progression in CTCL

Cosmin A Tegla, MD, Alberto M Herrera, MS, Angelina M Seffens, BS, Melania H Fanok, PhD, George Dean, MD, John Kawaoka, MD, Mary E Laird, MD, Yi Fulmer, PhD, Andreas Willerslev-Olsen, PhD, Kenneth B. Hymes, MD, Jo-Ann Latkowski, MD, Niels Odum, MD DMSci, Stefan Feske, MD, Bo Shopsin, MD PhD, Victor Torres, PhD, Marshall E. Kadin, MD, Larisa J Geskin, MD, Sergei B. Koralov, PhD

Blood (2019) 134 (Supplement_1): 659.

https://doi.org/10.1182/blood-2019-131917

Published: 2019

Journal Articles

A New Mechanism for T-ALL Leukemogenesis: Early Expression of Alpha-Beta TCR Occurs in a Natural Subset of CD4-CD8- Double Negative (DN) Thymocytes Where MHC Engagement May Drive NOTCH Mutation and Tumor Initiation

Kimberly G Laffey, PhD, Robert J Stiles, BS, Melissa Ludescher, MS, Tessa Davis, MS, Shariq S Khwaja, MD, Richard J. Bram, MD, Peter J Wettstein, PhD, Venkataraman Ramachandran, MD, Cory E Johnson, BS, Richard Hammer, MD, Chi-Ren Shyu, PhD, Diana Gil, PhD, Adam G Schrum, PhD

Blood (2019) 134 (Supplement_1): 1463.

https://doi.org/10.1182/blood-2019-131897

Published: 2019

Journal Articles

Versican Proteolytic Fragments (Matrikines) Regulate the Intratumoral Dendritic Cell Milieu In Vivo: Implications for in Situ Tumor Vaccination

Athanasios Papadas, MD, Evan Flietner, BS, Zachary Morrow, BS, Joshua Wiesner, Alexander Cicala, Adam Pagenkopf, BS, Chelsea L. Hope, PhD, Adhithi Rajagopalan, BS, Zhi Wen, PhD, Philip Emmerich, Dustin Deming, Shigeki Miyamoto, PhD, Peiman Hematti, MD, Natalie Scott Callander, MD, Alexander Rakhmilevich, Mario Otto, MD PhD, Christian M. Capitini, MD, Jing Zhang, PhD, Fotis Asimakopoulos, PhDMBBChir,

Blood (2019) 134 (Supplement_1): 1210.

https://doi.org/10.1182/blood-2019-131582

Published: 2019

Journal Articles

Cold Plasma with Immunomodulatory Properties Has Significant Anti-Lymphoma Activities in Vitro and In Vivo

Fengdong Cheng, MD, Dayun Yan, PhD, Jie Chen, PhD, Michael Keidar, PhD, Eduardo Sotomayor, MD

Blood (2019) 134 (Supplement_1): 5307.

https://doi.org/10.1182/blood-2019-131065

Published: 2019

Journal Articles

Development of Acute Myeloid Leukemia Cell Membrane Coated Nanoparticles (AMCNPs) for Cancer Vaccination Immunotherapy

Daniel T Johnson, Ashley V Kroll, BS, Ronnie H Fang, PhD, Justin Kline, MD, Liangfang Zhang, PhD, Dong-Er Zhang, PhD

Blood (2018) 132 (Supplement 1): 4062.

https://doi.org/10.1182/blood-2018-99-117841

Published: 2018

Journal Articles

Ectonucleosidase CD39 Is Highly Expressed on ATLL Cells and Suppresses the Immune Response through the Adenosine Pathway

Yasuhiro Nagate, MD, Sachiko Ezoe, MD PhD, Jiro Fujita, MD PhD, Takafumi Yokota, MD PhD, Michiko Ichii, MD PhD, Akira Tanimura, Yukiko Doi, Tomoaki Ueda, Jun Toda, MD, Hirohiko Shibayama, MD PhD, Kenji Oritani, MD PhD, Yuzuru Kanakura, MD PhD

Blood (2018) 132 (Supplement 1): 3720.

https://doi.org/10.1182/blood-2018-99-118555

Published: 2018

Journal Articles

Calcium/Calmodulin Dependent Protein Kinase Kinase 2 (CaMKK2) Expressed in the Host Promotes Lymphoma Cells Growth By Controlling Myeloid Derived Suppressor Cells Expansion

Wei Huang, MD PhD, Yaping Liu, MD, Nelson J. Chao, MD, Luigi Racioppi, MD PhD

Blood (2018) 132 (Supplement 1): 272.

https://doi.org/10.1182/blood-2018-99-117147

Published: 2018

Journal Articles

Characterizing the Immunogenicity of DM-Sensitive and DM-Resistant Antigens

Anna Luise Bernhardt, Sascha Kretschmann, PhD, Judith Bausenwein, Heidi Balzer, Andreas Mackensen, MD, Anita Natalie Kremer, MD PhD

Blood (2018) 132 (Supplement 1): 3310.

https://doi.org/10.1182/blood-2018-99-112103

Published: 2018

Journal Articles

Transfusion with Stored Antigen-Negative Blood Impairs T Cell Cross Priming to Red Cell Alloantigen in a Subsequent Transfusion

Stuart P. Weisberg, MD PhD, Aidin Shabro, Lyla A Youssef, BA, Steven Spitalnik, MD, Eldad A. Hod, MD

Blood (2018) 132 (Supplement 1): 742.

https://doi.org/10.1182/blood-2018-99-116217

Published: 2018

Journal Articles

Evaluation of Oncolytic Viral Therapy Combined with or without Artificial Immunoadjuvant Cell Therapy in Immunocompetent Mouse Tumor Models

Weng-Chit Ung, MSc, Muneyoshi Futami, MD PhD, Kota Sato, MDPhD, Arinobu Tojo, MD PhD

Blood (2018) 132 (Supplement 1): 5793.

https://doi.org/10.1182/blood-2018-99-112789

Published: 2018

Journal Articles

Modeling Targeted Lymphodepletion with Radiolabeled CD45 Antibody As a Promising Preparative Regimen Prior to Adoptive Cell Therapy or CAR-T

Dale L Ludwig, PhD BS, Mark S. Berger, MD, Dadachova Ekaterina, PhD, Kevin Allen, PhD, Wojciech Dawicki

Blood (2018) 132 (Supplement 1): 5682.

https://doi.org/10.1182/blood-2018-99-119740

Published: 2018

Journal Articles

Disruption of TET2 Dioxygenase Enhances Antitumor Efficiency in CD8+ Tumor Infiltrating Lymphocytes

Minjung Lee, MS, Hongxiang Zeng, PhD, Jia Li, PhD, Wei Han, MS, Deqiang Sun, PhD, Yun Huang, PhD

Blood (2018) 132 (Supplement 1): 860.

https://doi.org/10.1182/blood-2018-99-115405

Published: 2018

Journal Articles

First Evidence of Dysfunctional Antigen-Specific T Cell Responses in Experimental CLL As a Model for Studies of Autologous T Cell-Based Therapies

Anne W. J. Martens, MSc, Felix M Wensveen, PhD, Ramon Arens, PhD, Eric Eldering, PhD, Gerritje J. W. van der Windt, PhD, Arnon P. Kater, MD

Blood (2018) 132 (Supplement 1): 3694.

https://doi.org/10.1182/blood-2018-99-114679

Published: 2018

Journal Articles

Rock Inhibitor Fasudil Reduces Leukocyte-Endothelium Interactions in the Microvasculature of a Sickle Cell Mouse Model of Allergic Inflammation

Athos Rodrigues Moraes, Hanan Chweih, BSc, Nicola Conran, PhD, Kleber Yotsumoto Fertrin, MD PhD, Fernando Ferreira Costa, MD PhD, Carla Fernanda Franco-Penteado, BSc, PhD

Blood (2017) 130 (Supplement 1): 961.

https://doi.org/10.1182/blood.V130.Suppl_1.961.961

Published: 2017

Journal Articles

Antigen-Mediated Immune Suppression Is Antigen Specific

Cheryl Maier, MD PhD, Amanda Mener, Seema R Patel, BS, PhD, Ashley L Bennett, BA, Sean R Stowell, MD PhD

Blood (2017) 130 (Supplement 1): 708.

https://doi.org/10.1182/blood.V130.Suppl_1.708.708

Published: 2017

Journal Articles

Marginal Zone B Cells Facilitate RBC Alloimmunization Independent of Direct CD4 + T Cell Activation

Patricia E Zerra, MD, Seema R Patel, BS, PhD, Ashley L Bennett, BA, Sean R Stowell, MD PhD

Blood (2017) 130 (Supplement 1): 2399.

https://doi.org/10.1182/blood.V130.Suppl_1.2399.2399

Published: 2017

Journal Articles

Memory T Cells from Minor Histocompatibility Antigen-Vaccinated Donors Improve Engraftment with Low Intensity Conditioning

Meng Zhou, Jinling Liu, PhD, Warren D Shlomchik, MD

Blood (2017) 130 (Supplement 1): 4436.

https://doi.org/10.1182/blood.V130.Suppl_1.4436.4436

Published: 2017

Journal Articles

Tolerization of CD4+ Recent Thymic Emigrants Is Required to Prevent RBC-Specific Autoimmunity

Andrea S.L. Wong, PhD, Amanda L Richards, Krystalyn E Hudson, PhD

Blood (2017) 130 (Supplement 1): 2283.

https://doi.org/10.1182/blood.V130.Suppl_1.2283.2283

Published: 2017

Journal Articles

Platelet-Targeted Gene Transfer Induces Immune Tolerance in a Primed Model

Jing Li, MD PhD, Juan Chen, PhD, Jocelyn Schroeder, Jianda Hu, MD PhD, Qizhen Shi, MD PhD

Blood (2017) 130 (Supplement 1): 4612.

https://doi.org/10.1182/blood.V130.Suppl_1.4612.4612

Published: 2017

NARROW

RIG-I Activation Is Critical for Responsiveness to Checkpoint Blockade

Skin Associated Staphylococcus Aureus Contributes to Disease Progression in CTCL

A New Mechanism for T-ALL Leukemogenesis: Early Expression of Alpha-Beta TCR Occurs in a Natural Subset of CD4-CD8- Double Negative (DN) Thymocytes Where MHC Engagement May Drive NOTCH Mutation and Tumor Initiation

Versican Proteolytic Fragments (Matrikines) Regulate the Intratumoral Dendritic Cell Milieu In Vivo: Implications for in Situ Tumor Vaccination

Cold Plasma with Immunomodulatory Properties Has Significant Anti-Lymphoma Activities in Vitro and In Vivo

Development of Acute Myeloid Leukemia Cell Membrane Coated Nanoparticles (AMCNPs) for Cancer Vaccination Immunotherapy

Ectonucleosidase CD39 Is Highly Expressed on ATLL Cells and Suppresses the Immune Response through the Adenosine Pathway

Calcium/Calmodulin Dependent Protein Kinase Kinase 2 (CaMKK2) Expressed in the Host Promotes Lymphoma Cells Growth By Controlling Myeloid Derived Suppressor Cells Expansion

Characterizing the Immunogenicity of DM-Sensitive and DM-Resistant Antigens

Transfusion with Stored Antigen-Negative Blood Impairs T Cell Cross Priming to Red Cell Alloantigen in a Subsequent Transfusion

Evaluation of Oncolytic Viral Therapy Combined with or without Artificial Immunoadjuvant Cell Therapy in Immunocompetent Mouse Tumor Models

Modeling Targeted Lymphodepletion with Radiolabeled CD45 Antibody As a Promising Preparative Regimen Prior to Adoptive Cell Therapy or CAR-T

Disruption of TET2 Dioxygenase Enhances Antitumor Efficiency in CD8+ Tumor Infiltrating Lymphocytes

First Evidence of Dysfunctional Antigen-Specific T Cell Responses in Experimental CLL As a Model for Studies of Autologous T Cell-Based Therapies

Rock Inhibitor Fasudil Reduces Leukocyte-Endothelium Interactions in the Microvasculature of a Sickle Cell Mouse Model of Allergic Inflammation

Antigen-Mediated Immune Suppression Is Antigen Specific

Marginal Zone B Cells Facilitate RBC Alloimmunization Independent of Direct CD4 + T Cell Activation

Memory T Cells from Minor Histocompatibility Antigen-Vaccinated Donors Improve Engraftment with Low Intensity Conditioning

Tolerization of CD4+ Recent Thymic Emigrants Is Required to Prevent RBC-Specific Autoimmunity

Platelet-Targeted Gene Transfer Induces Immune Tolerance in a Primed Model

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only